Emtricitabine and Harvoni drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emtricitabine (emtricitabine) and Harvoni (ledipasvir; sofosbuvir). Common drug interactions include anxiety among females and congestive cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Emtricitabine and Harvoni. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Emtricitabine?

Emtricitabine has active ingredients of emtricitabine. eHealthMe is studying from 6,391 Emtricitabine users. Check the latest studies of Emtricitabine.

What is Harvoni?

Harvoni has active ingredients of ledipasvir; sofosbuvir. eHealthMe is studying from 19,858 Harvoni users. Check the latest studies of Harvoni.

On Jul, 17, 2026

15 people who take Emtricitabine and Harvoni together, and have interactions are studied.

Emtricitabine and Harvoni drug interactions.

What are the common drug interactions of Emtricitabine and Harvoni, by gender? *:

female:

Anxiety
Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
Crying
Depressive symptom
Diarrhoea
Initial insomnia (feeling of inadequate or poor-quality sleep)
Mood altered (changes in mood)
Nervousness
Osteoporosis (bones weak and more likely to break)
Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)

male:

Congestive cardiomyopathy (weakening of heart muscle)
Drug resistance (reduction in effectiveness of a drug)
Malaise (a feeling of general discomfort or uneasiness)
Substance-induced psychotic disorder
Neoplasm malignant (cancer tumour)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Blood bilirubin increased
Drug ineffective
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

What are the common drug interactions of Emtricitabine and Harvoni, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Congestive cardiomyopathy (weakening of heart muscle)
Drug resistance (reduction in effectiveness of a drug)
Neoplasm malignant (cancer tumour)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Drug ineffective
Hepatitis c
Substance-induced psychotic disorder

50-59:

Initial insomnia (feeling of inadequate or poor-quality sleep)
Mood altered (changes in mood)
Nervousness
Osteoporosis (bones weak and more likely to break)
Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
Sleep disorder
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Anxiety
Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)
Crying

60+:

Blood bilirubin increased
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Hiv Infection: 11 people, 73.33%
Hepatitis C: 11 people, 73.33%
Type 2 Diabetes: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Emtricitabine and Harvoni?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously